跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ALMOTRIPTAN
Authorized
STANDARD
ALMOTRIPTAN
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
66fcb1696d40c6c1
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
66fcb1696d40c6c1
Drug Approval Canada Name
ALMOTRIPTAN
Product Name
ALMOTRIPTAN
Status
Marketed
Status Date
2018-03-06
Original Market Date
2018-03-06
Din
02466821
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC05 ALMOTRIPTAN
Atc Name
n 02 cc 05
Aig Number
0149521002
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
ALMOTRIPTAN (ALMOTRIPTAN MALATE)
12.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
66fcb1696d40c6c1
Type
Standard
Back to Health Canada Approvals
ALMOTRIPTAN - Health Canada Drug Approval Details